The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis
Authors
Keywords
-
Journal
NATURE GENETICS
Volume 47, Issue 11, Pages 1346-1351
Publisher
Springer Nature
Online
2015-10-13
DOI
10.1038/ng.3419
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AR function in promoting metastatic prostate cancer
- (2014) Michael A. Augello et al. CANCER AND METASTASIS REVIEWS
- A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding
- (2014) Qilai Huang et al. NATURE GENETICS
- Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
- (2013) Warren A. Whyte et al. CELL
- In vitro model systems to study androgen receptor signaling in prostate cancer
- (2013) Natalie Sampson et al. ENDOCRINE-RELATED CANCER
- Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma
- (2013) Leilei Chen et al. NATURE MEDICINE
- Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype
- (2013) J L L Robinson et al. ONCOGENE
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- The Androgen Receptor Induces a Distinct Transcriptional Program in Castration-Resistant Prostate Cancer in Man
- (2012) Naomi L. Sharma et al. CANCER CELL
- ATARiS: Computational quantification of gene suppression phenotypes from multisample RNAi screens
- (2012) D. D. Shao et al. GENOME RESEARCH
- Differential DNase I hypersensitivity reveals factor-dependent chromatin dynamics
- (2012) Housheng Hansen He et al. GENOME RESEARCH
- HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG)
- (2012) Jianfeng Xu et al. HUMAN GENETICS
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer
- (2012) Christopher E Barbieri et al. NATURE GENETICS
- Identifying ChIP-seq enrichment using MACS
- (2012) Jianxing Feng et al. Nature Protocols
- Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks
- (2012) Cole Trapnell et al. Nature Protocols
- Germline Mutations inHOXB13and Prostate-Cancer Risk
- (2012) Charles M. Ewing et al. NEW ENGLAND JOURNAL OF MEDICINE
- The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
- (2011) Charles E Massie et al. EMBO JOURNAL
- Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA
- (2011) Dong Wang et al. NATURE
- The genomic complexity of primary human prostate cancer
- (2011) Michael F. Berger et al. NATURE
- Cistrome: an integrative platform for transcriptional regulation studies
- (2011) Tao Liu et al. GENOME BIOLOGY
- An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
- (2010) Jindan Yu et al. CANCER CELL
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell Identities
- (2010) Sven Heinz et al. MOLECULAR CELL
- Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
- (2009) Qianben Wang et al. CELL
- Cistromics of hormone-dependent cancer
- (2009) Mathieu Lupien et al. ENDOCRINE-RELATED CANCER
- Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
- (2009) Ben Langmead et al. GENOME BIOLOGY
- Model-based Analysis of ChIP-Seq (MACS)
- (2008) Yong Zhang et al. GENOME BIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started